Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
TargeGen, Inc. logo — company profile

TargeGen, Inc.

Founded 2002 4 employees Debt Financing Total: $113.72M Biopharma, Biotechnology +1

General Information

Company Name TargeGen, Inc.
Founded Year 2002
Employees 4
Industries Biopharma, Biotechnology, Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with TargeGen, Inc.. To contact TargeGen, Inc., visit targegen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TargeGen, Inc. compare?

A PDF of TargeGen, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TargeGen, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TargeGen, Inc.

TargeGen, Inc. is a biopharmaceutical startup founded in 2002. Specializing in biotechnology and healthcare, the company received a $3.73M debt financing investment on 21 September 2009. TargeGen's core activities include supervising day-to-day accounting functions such as GL, AP, purchasing, fixed assets, and payroll. They are also responsible for month-end closing, financial reporting, treasury functions, year-end audit, Federal and State tax filings.

Business keywords: biopharmaceutical, vascular biology, small molecule kinase inhibitors, vascular leakage, angiogenesis, inflammation, heart disease, cancer treatment, eye diseases, macular degeneration, oncology, inflammatory diseases, San Diego, acquisition, pharmaceutical

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $3.73M -
21 Sep 2009
Series D $40.00M 10
Forward Ventures BB Biotech Ventures Chicago Growth Partners
Forward Ventures, BB Biotech Ventures +8
12 Jul 2007
Series C $29.99M -
26 Sep 2005
Series B $30.00M -
15 Jan 2004
Series A $10.00M -
31 May 2002

TargeGen, Inc. Alternatives & Competitors

View All Alternatives
TargeGen, Inc. vs
Ambit
Ambit

Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kinase inhibit...

Venture round
197 employees
Biopharma, Biotechnology
TargeGen, Inc. vs
Plexxikon Inc.
Plexxikon Inc. United States

Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of nov...

Series B
15 employees
Biotechnology, Health Care
TargeGen, Inc. vs
Amgen
Amgen United States

#WeareBiotech

IPO
40947 employees
Biotechnology, Health Care
View all alternatives

FAQ About TargeGen, Inc.

- Supervised day-to-day accounting functions including GL, AP, purchasing, fixed assets and payroll. - Responsilbe for month-end closing. - Responsible for financial reporting. - Responsible for treasury functions. - Responsible for year-end audit. - Responsible for Federal and State tax filing...
TargeGen, Inc. was founded in 2002.
TargeGen, Inc. operates in Biopharma, Biotechnology and Health Care. Its work centres on biopharmaceutical, vascular biology, small molecule kinase inhibitors and vascular leakage.
TargeGen, Inc. has approximately 4 employees.
TargeGen, Inc. has completed 5 funding rounds, raising a total of $113.72M. The latest funding stage is Debt Financing.
Top alternatives and competitors to TargeGen, Inc. include Ambit, Plexxikon Inc., Amgen, VentiRx Pharmaceuticals, MethylGene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TargeGen, Inc. and Ambit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TargeGen, Inc., https://bouncewatch.com/company/targegen-inc, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout